Iveric Bio Inc
(ISEE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 6,390 |
| Other current assets | 0 | 0 | 0 | 0 | 1,100 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7,490 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 190 |
| Investments And Advances | 0 | 0 | 0 | 0 | 150 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $340 |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $7,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 850 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,270 |
| Other current liabilities | N/A | N/A | N/A | N/A | 210 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $3,330 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 213,740 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $213,740 |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $110,210 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | N/A | 2 |
| Retained earnings | N/A | N/A | N/A | N/A | -105,480 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 2,999 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $-102,480 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $7,730 |